(Albany, US) DelveInsight has launched a new report on “Presbyopia Market Insights, Epidemiology, and Market Forecast-2030“.

DelveInsight’s “Presbyopia Market Insights, Epidemiology, and Market Forecast-2030“ report delivers an in-depth understanding of the Presbyopia , historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the facts:

• It was estimated that there were 1.8 billion people globally with presbyopia in 2015, 826 million of whom had near vision impairment (VI) because they had no, or inadequate, vision correction.
• The mean age of presbyopia was estimated to be 44.7±7.5 years and the male to female ratio was 1:2.2.
• Expected launch of CSF-1 (Orasis Pharmaceuticals Ltd), AGN 190584 (Allergan), and UNR844-Cl (Novartis Pharmaceuticals) shall fuel the growth of the market during the forecast period i.e., 2017-2030.

 

Request for Free Sample report: https://www.delveinsight.com/sample-request/presbyopia-market

Scope of the Report

• The report covers the descriptive overview of Presbyopia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Presbyopia epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Presbyopia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Presbyopia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Presbyopia market

 

“Presbyopia is more common in females as compared to the males.”

Request for Free Sample report: https://www.delveinsight.com/sample-request/presbyopia-market

Presbyopia is a vision condition in which the shape of the crystalline lens of eye changes. These changes make it difficult to focus on close objects. Presbyopia may seem to occur suddenly, but sight reduction occurs over a number of years. Presbyopia usually becomes noticeable in the early to mid-40s, but the reduction of accommodation starts as early as childhood. Presbyopia is a natural part of the aging process of the eye. It is not a disease, and it cannot be prevented.

Presbyopia is an age-related process and it is a gradual thickening and loss of flexibility of the natural lens inside eye. These age-related changes occur within the proteins in the lens, making the lens harder and less elastic over time. Age-related changes also take place in the muscle fibers surrounding the lens. With less elasticity, it gets difficult for the eyes to focus on close objects. Signs and symptoms include: hard time reading small print, having to hold reading material farther than arm’s distance, problems seeing objects that are close, headaches and eye strain.

There are five types of presbyopia:

• Incipient presbyopia: This is the very earliest stage, when it may be a bit more difficult to read small print.
• Functional presbyopia: This occurs when patient begin to notice more problems with near sight.
• Absolute presbyopia: If patient have this type, eyes cannot focus on near objects at all.
• Premature presbyopia: This term is used when presbyopia occurs before the age of 40 years.
• Nocturnal presbyopia: When this occurs, focusing on near objects is particularly difficult in low light conditions.

 

Request for Free Sample report: https://www.delveinsight.com/sample-request/presbyopia-market

 

Some of the Presbyopia Companies:

• Orasis Pharmaceuticals Ltd
• Allergan
• And Many Others

 

Presbyopia Drugs Covered:

• CSF-1
• AGN 190584
• And Many Others

Request for Free Sample report: https://www.delveinsight.com/sample-request/presbyopia-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Presbyopia

3. Competitive Intelligence Analysis for Presbyopia

4. Presbyopia : Market Overview at a Glance

4.1. Presbyopia Total Market Share (%) Distribution in 2017

4.2. Presbyopia Total Market Share (%) Distribution in 2030

5. Presbyopia : Disease Background and Overview

6. Patient Journey

7. Presbyopia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Presbyopia Treatment and Management

8.2. Presbyopia Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Presbyopia Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Presbyopia : Seven Major Market Analysis

13.1. Key Findings

13.2. Presbyopia Market Size in 7MM

13.3. Presbyopia Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Presbyopia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

Related Reports:

• Presbyopia – Pipeline Insights, 2020
• Presbyopia – Epidemiology Forecast to 2030

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/presbyopia-market